Dr. Sandrine Niyongere

Claim this profile

University of Maryland/Greenebaum Cancer Center

Studies Myelodysplastic Syndromes
Studies Leukemia
3 reported clinical trials
7 drugs studied

Affiliated Hospitals

Image of trial facility.
University Of Maryland/Greenebaum Cancer Center
Image of trial facility.
University Of Maryland

Clinical Trials Sandrine Niyongere is currently running

Image of trial facility.

Venetoclax + ASTX727

for Chronic Myelomonocytic Leukemia

This trial is testing if a combination of two drugs, ASTX727 and venetoclax, is more effective than ASTX727 alone in treating certain bone marrow cancers. It focuses on patients with CMML and MDS/MPN who have too many immature blood cells. ASTX727 helps produce normal blood cells and kills abnormal ones, while venetoclax blocks a protein that cancer cells need to survive. Venetoclax is an anticancer drug used to treat lymphomas and leukemias, but it has severe side effects.
Recruiting1 award Phase 2

More about Sandrine Niyongere

Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Sandrine Niyongere has experience with
  • CC-95251
  • Azacitidine
  • Navtemadlin
  • Idarubicin Hydrochloride
  • Cytarabine
  • Venetoclax
Breakdown of trials Sandrine Niyongere has run
Myelodysplastic Syndromes
Leukemia
Granulocytic Leukemia
Acute Myeloid Leukemia
CHILD Syndrome

Other Doctors you might be interested in

Hyun KimUniversity of Minnesota
Yixing Jiang, MD, PhDUniversity of Maryland Medical Center
Seung T LeeUniversity of Maryland

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sandrine Niyongere specialize in?
Sandrine Niyongere focuses on Myelodysplastic Syndromes and Leukemia. In particular, much of their work with Myelodysplastic Syndromes has involved p53 positive patients, or patients who are undergoing treatment.
Is Sandrine Niyongere currently recruiting for clinical trials?
Yes, Sandrine Niyongere is currently recruiting for 1 clinical trial in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Sandrine Niyongere has studied deeply?
Yes, Sandrine Niyongere has studied treatments such as CC-95251, Azacitidine, Navtemadlin.
What is the best way to schedule an appointment with Sandrine Niyongere?
Apply for one of the trials that Sandrine Niyongere is conducting.
What is the office address of Sandrine Niyongere?
The office of Sandrine Niyongere is located at: University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland 21201 United States. This is the address for their practice at the University of Maryland/Greenebaum Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top